Evaluating the expression of urokinase and tissue leukocyte being in benign and malignant breast disease

Izzo S.; Izzo L.; Gabriele R.; Spunticchia F.; Costi U.; De Santis A.; Pugliese F.; Pagni P.; Izzo P.

Volume : VII, Issue : I, January - 2018

Evaluating the expression of urokinase and tissue leukocyte being in benign and malignant breast disease

Izzo S. , Izzo L. , Gabriele R. , Spunticchia F. , Costi U. , De Santis A. , Pugliese F. , Pagni P. , Izzo P.

Abstract :

Introduction: Our objectives is to show that the expression of uPA leukocyte could be considered, in the future, as a marker of the expression of uPA in the malignant tissue and therefore a potential indicator of prognosis.

Methods: We examined the expression of uPa in leukocytes and tissues of three groups of women: with east cancer; with benign east lesion and healthy women (control group). We used RT Real Time PCR assay. The expression of urokinase is significantly higher in malignant east lumps compared to benign lesions. However, in women with carcinoma of the east, malignant tissue expresses higher amounts of uPA than the healthy counterpart. There are no statistically significant differences in the expression of uPA, between tissues taken from women with benign lesions. The lymphocytes taken from healthy volunteers show a level of expression of uPA significantly lower than the other tested samples Lymphocytes extracted from cancer patients express higher amounts of uPA compared to lymphocytes belonging to women with benign east lesions. The expression of uPA was compared with the clinical and biological parameters commonly used in clinical practice for the definition of the prognosis. The only exception found, concerns those tumors characterized by the simultaneous negativity for estrogen receptors, progesterone and HER2 (state of triple negative), in which the expression of uPA is very high.

Results and conclusions: Our data show that uPA expressed by leukocytes of each individual patient is the mirror image of the one expressed by malignant nodular uPA.